[go: up one dir, main page]

MX2013011151A - Proceso para la preparacion de 1-(2-metil-4-(2,3,4,5-tetrahidro-1- benzazepin-1-il-carbonil)benzilcarbamoil)-l-prolina-n,n-dimetilam ida. - Google Patents

Proceso para la preparacion de 1-(2-metil-4-(2,3,4,5-tetrahidro-1- benzazepin-1-il-carbonil)benzilcarbamoil)-l-prolina-n,n-dimetilam ida.

Info

Publication number
MX2013011151A
MX2013011151A MX2013011151A MX2013011151A MX2013011151A MX 2013011151 A MX2013011151 A MX 2013011151A MX 2013011151 A MX2013011151 A MX 2013011151A MX 2013011151 A MX2013011151 A MX 2013011151A MX 2013011151 A MX2013011151 A MX 2013011151A
Authority
MX
Mexico
Prior art keywords
preparation
benzazepin
benzylcarbamoyl
dimethylamide
ylcarbonyl
Prior art date
Application number
MX2013011151A
Other languages
English (en)
Inventor
Valerie Elizabeth Peal
Original Assignee
Vantia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vantia Ltd filed Critical Vantia Ltd
Publication of MX2013011151A publication Critical patent/MX2013011151A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a un nuevo proceso para la preparación de un polimorfo cristalino de un agonista de vasopresina V2.
MX2013011151A 2011-03-31 2012-03-30 Proceso para la preparacion de 1-(2-metil-4-(2,3,4,5-tetrahidro-1- benzazepin-1-il-carbonil)benzilcarbamoil)-l-prolina-n,n-dimetilam ida. MX2013011151A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161469904P 2011-03-31 2011-03-31
GBGB1105537.3A GB201105537D0 (en) 2011-03-31 2011-03-31 New process
PCT/GB2012/050720 WO2012131389A1 (en) 2011-03-31 2012-03-30 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide

Publications (1)

Publication Number Publication Date
MX2013011151A true MX2013011151A (es) 2014-04-16

Family

ID=44071798

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011151A MX2013011151A (es) 2011-03-31 2012-03-30 Proceso para la preparacion de 1-(2-metil-4-(2,3,4,5-tetrahidro-1- benzazepin-1-il-carbonil)benzilcarbamoil)-l-prolina-n,n-dimetilam ida.

Country Status (12)

Country Link
US (1) US9145397B2 (es)
EP (1) EP2691390B1 (es)
JP (1) JP5889391B2 (es)
KR (1) KR101903641B1 (es)
CN (1) CN103562203B (es)
BR (1) BR112013024978A2 (es)
CA (1) CA2867781C (es)
ES (1) ES2555480T3 (es)
GB (1) GB201105537D0 (es)
MX (1) MX2013011151A (es)
RU (1) RU2594164C2 (es)
WO (1) WO2012131389A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
HUP0103064A3 (en) * 2001-07-26 2005-06-28 Egis Gyogyszergyar Nyilvanosan Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
TWI459947B (zh) 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
GB201005623D0 (en) * 2010-04-01 2010-05-19 Vantia Ltd New polymorph
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process

Also Published As

Publication number Publication date
CN103562203A (zh) 2014-02-05
KR20140047037A (ko) 2014-04-21
WO2012131389A1 (en) 2012-10-04
CN103562203B (zh) 2015-01-07
BR112013024978A2 (pt) 2017-02-07
US20140066619A1 (en) 2014-03-06
JP2014509638A (ja) 2014-04-21
JP5889391B2 (ja) 2016-03-22
ES2555480T3 (es) 2016-01-04
EP2691390B1 (en) 2015-09-16
RU2013148584A (ru) 2015-05-10
RU2594164C2 (ru) 2016-08-10
US9145397B2 (en) 2015-09-29
CA2867781C (en) 2019-02-12
CA2867781A1 (en) 2012-10-04
HK1193612A1 (zh) 2014-09-26
EP2691390A1 (en) 2014-02-05
KR101903641B1 (ko) 2018-10-02
GB201105537D0 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
MA32977B1 (fr) Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol
PH12013500554A1 (en) Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
IL229647A0 (en) A new process for the preparation of prostaglandin amides
PL2901857T3 (pl) Sposób wytwarzania 3-chloro-4,5,6-trifluoro-pikolinonitrylu
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
IN2012DN01929A (es)
IN2013CH04906A (es)
IN2014DN09451A (es)
WO2013190357A8 (en) A process for the preparation of gabapentin
JO2930B1 (en) A new process for the synthesis of ivabradine and salts of addition with a pharmaceutically acceptable acid
EA201300719A2 (ru) Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина и применение в синтезе ивабрадина и его солей
MX2013011151A (es) Proceso para la preparacion de 1-(2-metil-4-(2,3,4,5-tetrahidro-1- benzazepin-1-il-carbonil)benzilcarbamoil)-l-prolina-n,n-dimetilam ida.
MX365948B (es) Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida.
NZ720805A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
NZ709054A (en) Improved processes for the preparation of 1-aryl-5-alkyl pyrazole compounds
WO2013072938A3 (en) Process for the preparation of roflumilast
TN2012000154A1 (en) Process for the manufacture of organic compounds
UY35108A (es) Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
WO2014060575A3 (en) Process for the enantioselective synthesis of a tetrahydrobenzazepine compound
MX345822B (es) Separacion de enantiomeros derivados de triazina usando acido tartarico.
UY35561A (es) Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
MX2013002656A (es) Nuevo proceso.
IN2013MU03670A (es)
WO2013054273A3 (en) Process for the preparation of agomelatine

Legal Events

Date Code Title Description
FG Grant or registration